HBIO icon

Harvard Bioscience

84 hedge funds and large institutions have $129M invested in Harvard Bioscience in 2015 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 28 increasing their positions, 25 reducing their positions, and 13 closing their positions.

Holders
84
Holders Change
+5
Holders Change %
+6.33%
% of All Funds
2.27%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
18
Increased
28
Reduced
25
Closed
13
Calls
Puts
$54K
Net Calls
-$54K
Net Calls Change
-$61K
Name Market Value Shares Shares
Change
Shares
Change %
Bank of America
76
Bank of America
North Carolina
$11K 2,006 +2,006 New
UBS Group
77
UBS Group
Switzerland
$10K 1,750 -261 -13%
Group One Trading
78
Group One Trading
Illinois
$6K 1,000 +1,000 New
Invesco
79
Invesco
Georgia
$6K 1,040 +1,040 New
Citigroup
80
Citigroup
New York
$3K 668 +452 +209%
Barclays
81
Barclays
United Kingdom
$3K 640 +640 New
LTFS
82
Ladenburg Thalmann Financial Services
Florida
$2K 300
SEI Investments
83
SEI Investments
Pennsylvania
$1K 173 -15 -8%
Manulife (Manufacturers Life Insurance)
84
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$161 28,326 +28,326 New
EI
85
EAM Investors
California
-269,442 Closed
FA
86
Friess Associates
Delaware
-90,000 Closed
PSC
87
Piper Sandler & Co
Minnesota
-75,000 Closed
HIM
88
Hillsdale Investment Management
Ontario, Canada
-49,300 Closed
WA
89
Whitebox Advisors
Minnesota
-39,739 Closed
NCCM
90
Nine Chapters Capital Management
New Jersey
-27,800 Closed
Millennium Management
91
Millennium Management
New York
-23,199 Closed
RC
92
RBF Capital
California
-20,000 Closed
YCM
93
Yakira Capital Management
Connecticut
-13,090 Closed
Janney Montgomery Scott
94
Janney Montgomery Scott
Pennsylvania
-10,550 Closed
Susquehanna International Group
95
Susquehanna International Group
Pennsylvania
-10,017 Closed
BJ
96
BlackRock Japan
Japan
-9,570 Closed
Federated Hermes
97
Federated Hermes
Pennsylvania
-350 Closed